Evaluation of the Bounce Back Program

Sponsor
University of British Columbia (Other)
Overall Status
Unknown status
CT.gov ID
NCT01324648
Collaborator
Canadian Institutes of Health Research (CIHR) (Other), Canadian Mental Health Association (Other)
213
3
3
45
71
1.6

Study Details

Study Description

Brief Summary

Lifetime prevalence rates of Major Depressive Disorder (MDD) in Canada are between 10-12% with approximately 1.5 million Canadians reporting depression in any given year. Alarmingly, the burden of ill health associated with MDD is projected to increase worldwide such that by the year 2020, depression will move from its current position of fourth to become the second greatest burden of ill health, closely following ischaemic heart disease (Murray & Lopez, 1998). As depressed patients are often in frequent contact with their primary care physicians for other health problems, effective depression treatment and management currently relies heavily on the primary care sector. Cognitive behavioural therapy (CBT) is an empirically supported psychotherapy that is recommended by the Canadian Network for Mood and Anxiety Treatments Clinical Guidelines as a first-line treatment for depression. However, across Canada, CBT is not readily accessible by primary care physicians for their patients, particularly in rural areas.

To help address this nationwide need for CBT, British Columbia (BC) is the first and only province in Canada to develop and implement a high capacity mental health service, Bounce Back: Reclaim your Health (BB), for primary care patients with mild to moderate depression. In BB, the patients' use of Cognitive-Behavioural Therapy (CBT) self-help materials is supported via trained telephone coaches.

The primary objective of our proposed research is to provide direct evidence of the effectiveness of the BB program, and, in particular, the telephone coaching component. The investigators will test: (1) whether the BB program is more effective than general practitioner (GP) treatment-as-usual (TAU); and (2) whether BB's positive results can be attributed to the telephone coaching component, as this component is associated with the most significant costs of the program. A secondary objective is to assess the cost-effectiveness of such telephone support.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Telephone-supported self-help and GP treatment as usual
  • Behavioral: Unsupported self-help and GP treatment as usual
  • Other: General practitioner treatment as usual
N/A

Detailed Description

This proposed project is designed to evaluate and provide direct evidence for the clinical effectiveness of the Bounce Back: Reclaim your Health (BB) project currently implemented in 17 communities in British Columbia (BC). BB is an innovative mental health service in the health care system designed to help patients participate in their own care by teaching them the sufficient and necessary skills to manage their moods. This BB program, led by the Canadian Mental Health Association's BC Division, offers mental health support to primary care patients suffering from mild to moderate depression. BB is a low intensity, high capacity program, based on cognitive behaviour therapy (CBT) self-help materials Overcoming Depression, Low Mood and Anxiety: A five areas approach (OD - comprising psycho-educational DVD and self-help mood improvement workbook). The content of these self-help materials was adapted to a BC context for the BB program. In addition, in order to best meet the needs of BC primary care patients, this new mental health service is delivered to patients in their own homes and patients' use of the OD self-help materials is supported via trained telephone coaches. Telephone coaches are non-specialists trained and monitored by a registered psychologist. Coaching enables patients to engage with and get the most out of the materials. The advantages of telephone coaching include privacy, accessibility, and convenience, especially for those patients living in rural areas and can not access treatment due to geographic barriers; those who do not seek treatment due to stigma; or those who are coping with chronic physical illness and multiple medical appointments. There is only indirect support for the effectiveness of the BB program. Thus, this proposed project is designed to evaluate and provide direct evidence of the effectiveness of the BB program.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
213 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Investigator)
Primary Purpose:
Treatment
Official Title:
A Randomized Controlled Trial Evaluation of Brief, Telephone Supported CBT Self-help in Primary Care Patients With Mild to Moderate Depression
Study Start Date :
Mar 1, 2011
Anticipated Primary Completion Date :
Dec 1, 2014
Anticipated Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: TG + GP TAU

Behavioral: Telephone-supported self-help and GP treatment as usual
Participants' use of the BB self-help materials will be supported by three to five telephone coaching sessions that occur approximately every 2-3 weeks. Total contact time will be approximately 2 hours (2 hour total contact time will be considered "brief" in our study). Participants will also continue to receive whatever current treatment their general practitioner is providing.

Experimental: UG + GP TAU

Behavioral: Unsupported self-help and GP treatment as usual
This treatment was chosen as a control for the telephone coaching component of the BB program. Participants will be sent a package containing the BB self-help materials and along with instructions on how to utilize these materials. Participants will use the materials on their own and at their own pace. Participants will also continue to receive whatever current treatment their general practitioner is providing.

Active Comparator: GP TAU

Other: General practitioner treatment as usual
This group will receive treatment as usual - whereby the clinic staff will inform the participant's GP of their PHQ-9 score. They will also be informed that their GP will be contacted that they are taking part in the research and that their GP will continue to support them with their depression as usual.

Outcome Measures

Primary Outcome Measures

  1. Changes in levels of depressive symptomatology [The PHQ-9 will be assessed at screening, 2 month, 4 month, and 12 month time points.]

    Levels of depressive symptomatology will be measured over time, using the Patient Health Questionnaire (PHQ-9)

Secondary Outcome Measures

  1. Changes of levels of anxiety [The GAD-7 will be assessed at baseline, 2 month, 4 month, and 12 month time points]

    Levels of anxiety will be measured over tiem, using the Generalized Anxiety Disorder 7 (GAD-7).

  2. Changes in quality of life and enjoyment [The QLES-Q-SF will be assessed at baseline, 2 month, 4 month, and 12 month time points]

    Quality of life and enjoyment will be measured over time using the Quality of Life and Enjoyment Satisfaction Questionnaire (QLES-Q-SF).

  3. Changes in work and social adjustment [The WASA will be assessed at baseline, 2 month, 4 month, and 12 month time points]

    Work and social adjustemnt will be assessed over time, using the Work and Social Adjustment Scale (WASA).

  4. Changes in work functionality and impairment [The LEAPS will be assessed at baseline, 2 month, 4 month, and 12 month time points]

    Work functionality and impairment will be assessed over time using the Lam Employment and Productivity Scale (LEAPS).

  5. Changes in mental health literacy [The MHL-Q will be assessed at baseline, 2 month, 4 month, and 12 month time points]

    Mental health literacy will be measured over time using the Mental Health Literacy questionnaire (MHL-Q).

  6. Changes in use of health services [The CSRI will be asssessed at screening, 4 month, and 12 month time points]

    Participants' use of health services will be assessed using the Client Service Receipt Inventory - modified (CSRI).

  7. Changes in health status [The EQ-5D will be assessed at baseline, 2 month, 4 month, and 12 month time points]

    Health status will be assessed using the Euroquol-5 (EQ-5D).

  8. Changes in health status and health related quality of life [The HUI-3 will be assesed at baseline, 2 month, 4 month, and 12 month time points]

    Health status and health related quality of life will be assessed over time using the Health Utilities Index (HUI-3).

  9. Changes in illness severity [The DUSOI will be assessed at baseline, 2 month, 4 month, and 12 month time points]

    Illness severity will be assessed over time using the Duke Severity of Illness Checklist (DUSOI).

  10. Client satisfaction. [The CSQ-9 will be assessed at 4 month time point.]

    Client satisfaction will be assessed using the Client Satisfaction Questionnaire 9 (CSQ-9).

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • currently experiencing a mild to moderate level of depressive symptoms as defined by a score of 5 - 19 on the PHQ-9;

  • 19 years of age or older

  • willing to use the BB program;

  • able to use the BB self-help materials with telephone coaching (have access to read, hear a telephone conversation and have a telephone); and,

  • ability to give informed consent and complete questionnaires unassisted.

Exclusion Criteria:
  • a SCID diagnosis (past or present) of: (a) Bipolar Disorder; (b) Schizophreniform Disorders; (c) Substance Abuse or Dependence (current or within the past six months); (d) Borderline or Antisocial Personality Disorder (based on GP's diagnosis); or (e) Cognitive Disorder (as the BB program is not appropriate for these individuals);

  • active suicidal intent, (as defined by a score of 2 or more on the BDI-II suicide item #9; those with passive suicidal ideation will be monitored;

  • impaired concentration and motivation (scoring 7 or more on the combined BDI-II items #15, 19 and 20 for energy, concentration difficulty and tiredness, respectively);

  • are currently receiving, or have received in the previous 6 months, CBT or guided self-help for depression; or,

  • are involved in other clinical research studies.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Calgary Foothills Primary Care Network Calgary Alberta Canada T3G0B4
2 Chinook Primary Care Network Chinook Valley Alberta Canada T1J013
3 University of British Columbia Vancouver British Columbia Canada V6T2A1

Sponsors and Collaborators

  • University of British Columbia
  • Canadian Institutes of Health Research (CIHR)
  • Canadian Mental Health Association

Investigators

  • Principal Investigator: Mark Lau, PhD, University of British Columbia

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
University of British Columbia
ClinicalTrials.gov Identifier:
NCT01324648
Other Study ID Numbers:
  • H08-02847
  • 106504
First Posted:
Mar 29, 2011
Last Update Posted:
Sep 10, 2014
Last Verified:
Sep 1, 2014
Keywords provided by University of British Columbia
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 10, 2014